EUVIMEDEUVIMED entdecken
Systematische ÜbersichtLeitlinieOpen Access · CC BY-NC 4.0

Epidemiology of infective endocarditis before versus after change of international guidelines: a systematic review

Michael L Williams iD, Mathew P Doyle, Nicholas McNamara, Daniel Tardo, Manish Mathew, Benjamin Robinson

Therapeutic Advances in Cardiovascular Disease · 2021-01 · 15

DOI: 10.1177/17539447211002687 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Therapeutic Advances in Cardiovascular Disease, online erschienen am 30.03.2021. Verfasst von Michael L Williams und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Royal Prince Alfred Hospital, 50 Missenden Road, Camperdown, NSW 2050, Australia. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

All major international guidelines for the management of infective endocarditis (IE) have undergone major revisions, recommending antibiotic prophylaxis (AP) restriction to high-risk patients or foregoing AP completely. We performed a systematic review to investigate the effect of these guideline changes on the global incidence of IE.

Methods

Electronic database searches were performed using Ovid Medline, EMBASE and Web of Science. Studies were included if they compared the incidence of IE prior to and following any change in international guideline recommendations. Relevant studies fulfilling the predefined search criteria were categorized according to their inclusion of either adult or pediatric patients. Incidence of IE, causative microorganisms and AP prescription rates were compared following international guideline updates.

Results

Sixteen studies were included, reporting over 1.3 million cases of IE. The crude incidence of IE following guideline updates has increased globally. Adjusted incidence increased in one study after European guideline updates, while North American rates did not increase. Cases of IE with a causative pathogen identified ranged from 62% to 91%. Rates of streptococcal IE varied across adult and pediatric populations, while the relative proportion of staphylococcal IE increased (range pre-guidelines 16–24.8%, range post-guidelines 26–43%). AP prescription trends were reduced in both moderate and high-risk patients following guideline updates.

Discussion

The restriction of AP to only high-risk patients has not resulted in an increase in the incidence of streptococcal IE in North American populations. The evidence of the impact of AP restriction on IE incidence is still unclear for other populations. Future population-based studies with adjusted incidence of IE, AP prescription rates and accurate pathogen identification are required to delineate findings further in these other regions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdolescentAgedAged, 80 and overAntibiotic ProphylaxisAntimicrobial StewardshipChildChild, PreschoolClinical Decision-MakingEndocarditis, BacterialFemaleHumansIncidenceMaleMiddle AgedPractice Guidelines as TopicRisk AssessmentRisk Factors

Stichwörter der Autor:innen

antibiotic prophylaxisguidelineinfective endocarditissystematic review

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery, Royal Prince Alfred Hospital, 50 Missenden Road, Camperdown, NSW 2050, Australia.
  • Department of Cardiothoracic Surgery, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • Centre for Human and Applied Physiology, School of Medicine, University of Wollongong, Keiraville, Australia.
  • Department of Cardiothoracic Surgery, Royal Prince Alfred Hospital, Sydney, Australia.
  • Department of Medicine, St Vincents Hospital, Sydney, NSW, Australia.
  • School of Medicine, University of Notre Dame, Sydney, NSW, Australia.

ORCID-Profile: Michael L Williams

Zitieren

APA

Williams, M. L., Doyle, M. P., McNamara, N., Tardo, D., Mathew, M., & Robinson, B. (2021). Epidemiology of infective endocarditis before versus after change of international guidelines: a systematic review. Therapeutic Advances in Cardiovascular Disease, 15. https://doi.org/10.1177/17539447211002687

Vancouver

Williams ML, Doyle MP, McNamara N, Tardo D, Mathew M, Robinson B. Epidemiology of infective endocarditis before versus after change of international guidelines: a systematic review. Therapeutic Advances in Cardiovascular Disease. 2021;15. doi:10.1177/17539447211002687

BibTeX
@article{Williams2021,
  author = {Williams, Michael L and Doyle, Mathew P and McNamara, Nicholas and Tardo, Daniel and Mathew, Manish and Robinson, Benjamin},
  title = {Epidemiology of infective endocarditis before versus after change of international guidelines: a systematic review},
  journal = {Therapeutic Advances in Cardiovascular Disease},
  year = {2021},
  volume = {15},
  doi = {10.1177/17539447211002687}
}
Kostenlos starten →